Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 53, 2024 - Issue 2
Submit an article Journal homepage
91
Views
0
CrossRef citations to date
0
Altmetric
Letter

Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor

NV Morsing1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, DenmarkORCID Iconhttps://orcid.org/0009-0005-8070-3834
ORCID Icon,
CM Andreasen1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, DenmarkORCID Iconhttps://orcid.org/0000-0002-2376-0446
ORCID Icon,
TA Rasmussen2 Department of Infectious Diseases, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0001-5354-2442
ORCID Icon &
LT Moll1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4132-0310
ORCID Icon
Pages 158-159 | Received 12 Nov 2023, Accepted 13 Dec 2023, Published online: 26 Jan 2024

References

  • Sepriano A, Kerschbaumer A, Smolen JS, Van Der Heijde D, Dougados M, Van Vollenhoven R, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2020;79:760–70.
  • Da Silva ACC, De Oliveira Nascimento D, Ferreira JRM, Guimarães-Pinto K, Freire-De-Lima L, Morrot A, et al. Immune responses in leishmaniasis: an overview. Trop Med Infect Dis 2022;7:54.
  • Lupia T, Corcione S, Fornari V, Rizzello B, Bosio R, Brusa MT, et al. Visceral leishmaniasis after anti-interleukin 17A (IL-17A) therapy in a patient affected by psoriatic arthritis. Trop Med Infect Dis 2022;7:319.
  • Khan A, Coakley G, Cosgrove C, Lockwood DNJ. Let off the leash: kala-azar following the use of tumour necrosis factor antibodies. BMJ Case Rep 2010;2010:bcr0420102878.
  • Martínez MJM, Ramos MJM, Pedreño PS. Cutaneous leishmaniasis: an opportunistic infection. Reumatol Clín 2017;13:181–2.
  • Gómez PN, Hidalgo IC, De La Paz Casas Hidalgo M, Sánchez RÁ, Delgado AR, Cabeza-Barrera J. Cutaneous leishmaniasis associated with TNF-α blockers: a case report. Eur J Hosp Pharm 2018;26:233–4.
  • Hakimi S, Rivière S, Del Giudice P, Dereure J, Quellec AL. Localized cutaneous leishmaniasis due to Leishmania infantum in a patient treated with infliximab. Dermatology 2009;220:63–5.
  • Mueller M, Fleischmann E, Grünke M, Schewe S, Bogner JR, Löscher T. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab. Am J Trop Med Hyg 2009;81:52–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.